CAS RN: 52240-08-1
3-(6-Oxo-1,6-dihydro-3-pyridazinyl)benzonitrile
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250708
1g / 5g / 25g / 100g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 52240-08-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
25g
≥95%
0
Out of Stock
Hong Kong
Inquiry
52240-08-1 / 3-(6-oxo-1H-pyridazin-3-yl)benzonitrile
Standard CAS: 52240-08-1
Multi CAS: No
Basic Information
copy
CAS
52240-08-1 copy
Multi CAS
No copy
Molecular Formula
C11H7N3O copy
Molecular Weight
197.190000 copy
Exact Mass
197.058912 copy
InChI
InChI=1S/C11H7N3O/c12-7-8-2-1-3-9(6-8)10-4-5-11(15)14-13-10/h1-6H,(H,14,15) copy
InChIKey
INFIYPRKBSENAH-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
12 copy
Rotatable bonds
1 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
55.01 copy
TPSA
69.54 copy
LogP / Solubility
WLOGP
1.31 copy
MLOGP
1.15 copy
XLogP3
1 copy
Consensus LogP
1.15 copy
Log S (ESOL)
-2.41 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.12 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.15 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.99 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy